Pancreatic cancer is often referred to as a “silent killer”—and for good reason. Its symptoms are vague, its onset subtle, and its detection notoriously difficult. Tragically, this means that most people are diagnosed too late, when treatment options are limited and outcomes are poor.  But one group of healthcare professionals may hold the key to earlier detection: community pharmacists. 

Immune-related adverse events can affect any organ system. Quick, accurate recognition is essential for improving patient outcomes.